Monthly Archives: November 2022

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 4 November 2022) has been published and includes articles on: Dupilumab (Dupixent▼): risk of ocular adverse reactions and need for prompt management Consultation with healthcare professionals: please complete our consultation to help influence how we communicate with you COVID-19 vaccines [...]

The post MHRA Drug Safety Update November 2022 appeared first on PSNC Website.

The Department of Health and Social Care (DHSC) has today (29/11/2022) granted the following list of price concessions for November 2022: Drug Pack size Price concession Bumetanide 1mg/5ml oral solution sugar free 150 £235.00 Celecoxib 100mg capsules 60 £5.72 Celecoxib 200mg capsules 30 £5.41 Chlorphenamine 2mg/5ml oral solution 150 £4.09 Chlorphenamine 2mg/5ml oral solution sugar [...]

The post November 2022 Price Concessions 4th Update appeared first on PSNC Website.

The Drug Tariff Category M pricelist for December 2022 has been published on the NHS Business Services Authority (NHSBSA) website. As part of the announcement of the CPCF arrangements for 2022/23 and 2023/24, it was agreed that £100m of excess margin which had been accrued by pharmacy contractors would be written off. The December Category [...]

The post December 2022 Category M prices uplift appeared first on PSNC Website.

The Department of Health and Social Care (DHSC) has via its Central Alerting System (CAS) published a letter advising that due to increasing flu levels in the community, Prescribers working in primary care may now prescribe, and community pharmacists may now supply antiviral medicines (oseltamivir and zanamivir) for the prophylaxis and treatment of influenza at [...]

The post DHSC permits use of antiviral medicines against influenza appeared first on PSNC Website.

Class 4 Medicines Defect Information: Oxycodone Hydrochloride 10mg/ml oral solution (Lucis Pharma Ltd) Drug alert number: EL (22)A/49 Date issued: 29 November 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Oxycodone Hydrochloride 10mg/ml oral solution, PL 42176/0015 Batch Number Expiry Date Pack Size First [...]

The post MHRA Class 4 Medicines Defect Information: Oxycodone Hydrochloride 10mg/ml oral solution (Lucis Pharma Ltd) appeared first on PSNC Website.